Gigi Georgiana Huang

Array ( [id] => 10897617 [patent_doc_number] => 08920827 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Keratin bioceramic compositions' [patent_app_type] => utility [patent_app_number] => 11/549748 [patent_app_country] => US [patent_app_date] => 2006-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 7127 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11549748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5193581 [patent_doc_number] => 20070082065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Therapeutic composition for the treatment of dry eye syndrome' [patent_app_type] => utility [patent_app_number] => 11/546088 [patent_app_country] => US [patent_app_date] => 2006-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4125 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082065.pdf [firstpage_image] =>[orig_patent_app_number] => 11546088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5177002 [patent_doc_number] => 20070178062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Treatment of presbyopia with picolinic acid and its analogs' [patent_app_type] => utility [patent_app_number] => 11/544647 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8896 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20070178062.pdf [firstpage_image] =>[orig_patent_app_number] => 11544647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5096141 [patent_doc_number] => 20070117750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'METHOD FOR ENHANCED OCULAR DRUG PENETRATION' [patent_app_type] => utility [patent_app_number] => 11/538836 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6994 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117750.pdf [firstpage_image] =>[orig_patent_app_number] => 11538836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5194357 [patent_doc_number] => 20070082841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Ocular administration of immunosuppressive agents' [patent_app_type] => utility [patent_app_number] => 11/528840 [patent_app_country] => US [patent_app_date] => 2006-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5272 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082841.pdf [firstpage_image] =>[orig_patent_app_number] => 11528840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4938309 [patent_doc_number] => 20080075628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'STERILIZED MINOCYCLINE AND RIFAMPIN-CONTAINING MEDICAL DEVICE' [patent_app_type] => utility [patent_app_number] => 11/535762 [patent_app_country] => US [patent_app_date] => 2006-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5888 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20080075628.pdf [firstpage_image] =>[orig_patent_app_number] => 11535762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5135667 [patent_doc_number] => 20070077296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Pharmaceutical Preparation containing Meloxicam' [patent_app_type] => utility [patent_app_number] => 11/532952 [patent_app_country] => US [patent_app_date] => 2006-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4142 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20070077296.pdf [firstpage_image] =>[orig_patent_app_number] => 11532952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545461 [patent_doc_number] => 20090155338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Chronotherapeutic Ocular Delivery System Comprising a Combination of Prostaglandin and a Beta-Blocker for Treating Primary Glaucoma' [patent_app_type] => utility [patent_app_number] => 11/992272 [patent_app_country] => US [patent_app_date] => 2006-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6395 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155338.pdf [firstpage_image] =>[orig_patent_app_number] => 11992272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5258780 [patent_doc_number] => 20070212412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'STABLE SOLID FORMULATION OF SERTINDOLE' [patent_app_type] => utility [patent_app_number] => 11/530404 [patent_app_country] => US [patent_app_date] => 2006-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5452 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212412.pdf [firstpage_image] =>[orig_patent_app_number] => 11530404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4733353 [patent_doc_number] => 20080050332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Method of skin care and/or treatment using glutaredoxin' [patent_app_type] => utility [patent_app_number] => 11/510166 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1648 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050332.pdf [firstpage_image] =>[orig_patent_app_number] => 11510166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149508 [patent_doc_number] => 20070049568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Control of induced elevated intraocular pressure' [patent_app_type] => utility [patent_app_number] => 11/510528 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3986 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049568.pdf [firstpage_image] =>[orig_patent_app_number] => 11510528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860337 [patent_doc_number] => 20080269187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Methods for Treatment and Prevention of Otitis Media Using Chemical Penetration Enhancers to Facilitate Transmembrane Drug Delivery Into the Middle Ear' [patent_app_type] => utility [patent_app_number] => 12/066656 [patent_app_country] => US [patent_app_date] => 2006-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3402 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269187.pdf [firstpage_image] =>[orig_patent_app_number] => 12066656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4999402 [patent_doc_number] => 20070042036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Fat-soluble drug composition' [patent_app_type] => utility [patent_app_number] => 11/505984 [patent_app_country] => US [patent_app_date] => 2006-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4592 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20070042036.pdf [firstpage_image] =>[orig_patent_app_number] => 11505984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5153848 [patent_doc_number] => 20070036731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Topical Delivery with a Carrier Fluid' [patent_app_type] => utility [patent_app_number] => 11/464100 [patent_app_country] => US [patent_app_date] => 2006-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5976 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20070036731.pdf [firstpage_image] =>[orig_patent_app_number] => 11464100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205712 [patent_doc_number] => 20070027194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'TREATMENT OF ACTINIC KERATOSES WITH CALCIUM CHANNEL BLOCKERS' [patent_app_type] => utility [patent_app_number] => 11/459562 [patent_app_country] => US [patent_app_date] => 2006-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7438 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027194.pdf [firstpage_image] =>[orig_patent_app_number] => 11459562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839427 [patent_doc_number] => 20080279912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Use of Cis-Epoxyeicosatrienoic Acids And Inhibitors of Soluble Epoxide Hydrolase to Alleviate Eye Disorders' [patent_app_type] => utility [patent_app_number] => 11/995379 [patent_app_country] => US [patent_app_date] => 2006-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14395 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279912.pdf [firstpage_image] =>[orig_patent_app_number] => 11995379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368487 [patent_doc_number] => 20090306046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'METHOD OF TREATMENT OF HORMONE DEPLETION INDUCED VASOMOTOR SYMPTOMS' [patent_app_type] => utility [patent_app_number] => 11/917456 [patent_app_country] => US [patent_app_date] => 2006-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2148 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306046.pdf [firstpage_image] =>[orig_patent_app_number] => 11917456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9216361 [patent_doc_number] => 08629161 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-14 [patent_title] => 'Preventive or remedy for glaucoma' [patent_app_type] => utility [patent_app_number] => 11/993101 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3829 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11993101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5148316 [patent_doc_number] => 20070048375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Effervescent preparation of a basic medicinally active substance' [patent_app_type] => utility [patent_app_number] => 11/454462 [patent_app_country] => US [patent_app_date] => 2006-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3415 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048375.pdf [firstpage_image] =>[orig_patent_app_number] => 11454462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519778 [patent_doc_number] => 20100203088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Silver Nanoparticle Dispersion Formulation' [patent_app_type] => utility [patent_app_number] => 11/921970 [patent_app_country] => US [patent_app_date] => 2006-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4461 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203088.pdf [firstpage_image] =>[orig_patent_app_number] => 11921970 [rel_patent_id] =>[rel_patent_doc_number] =>)